First Time Loading...

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 15.55 USD 5.57%
Updated: Apr 29, 2024

Arcus Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcus Biosciences Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Arcus Biosciences Inc
NYSE:RCUS
Revenue
$117m
CAGR 3-Years
15%
CAGR 5-Years
69%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.1B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
9%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

Arcus Biosciences Inc
Revenue Breakdown

Breakdown by Geography
Arcus Biosciences Inc

Not Available

Breakdown by Segments
Arcus Biosciences Inc

Total Revenue: 117m USD
100%
License And Development Services Revenue: 80m USD
68.4%
License And R&D Services: 79m USD
67.5%
Other Collaboration Revenue: 37m USD
31.6%
Access Rights: 33m USD
28.2%
R&D Services: 5m USD
4.3%
Show More
Show Less

See Also

What is Arcus Biosciences Inc's Revenue?
Revenue
117m USD

Based on the financial report for Dec 31, 2023, Arcus Biosciences Inc's Revenue amounts to 117m USD.

What is Arcus Biosciences Inc's Revenue growth rate?
Revenue CAGR 5Y
69%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Arcus Biosciences Inc have been 15% over the past three years , 69% over the past five years .